Systemic Treatment of Acute Myeloid Leukemia (AML)

This is a clinical practice guideline for adult patients with acute myeloid leukemia (AML), excluding acute promyelocytic leukemia, who are deemed suitable for intensive treatment. The guideline includes consideration of the most effective systemic post-remission treatment – consolidation and/or maintenance – for adults with previously untreated AML. The guideline also considers which patient characteristics are most important when making treatment decisions.